Tatiana Vedekhina

Dr. Tatiana Vedekhina

Department of Cell Biology, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Bio-logical Agency, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PTPolina Tikhonova
Polina Tikhonova
Iuliia PavlovaIuliia Pavlova
Iuliia Pavlova
EIEkaterina Isaakova
Ekaterina Isaakova
Vladimir Borisovich TsvetkovVladimir Borisovich Tsvetkov
Vladimir Borisovich Tsvetkov
ABAlexandra N. Bogomazova
Alexandra N. Bogomazova
Anna VarizhukAnna Varizhuk
Anna Varizhuk
G-quadruplex (G4) sites in the human genome frequently colocalize with CCCTC-binding factor (CTCF)-bound sites in CpG islands (CGIs). We aimed to clarify the role of G4s in CTCF positioning. Molecular modeling data suggested direct interactions, so we performed in vitro binding assays with quadruplex-forming sequences from CGIs in the human genome. G4s bound CTCF with Kd values similar to that of the control duplex, while respective i-motifs exhibited no affinity for CTCF. Using ChIP-qPCR assays, we showed that G4-stabilizing ligands enhance CTCF occupancy at a G4-prone site in STAT3 gene. In view of the reportedly increased CTCF affinity for hypomethylated DNA, we next questioned whether G4s also facilitate CTCF recruitment to CGIs via protecting CpG sites from methylation. Bioinformatics analysis of previously published data argued against such a possibility. Finally, we questioned whether G4s facilitate CTCF recruitment by affecting chromatin structure. We showed that three architectural chromatin proteins of the high mobility group colocalize with G4s in the genome and recognize parallel-stranded or mixed-topology G4s in vitro. One of such proteins, HMGN3, contributes to the association between G4s and CTCF according to our bioinformatics analysis. These findings support both direct and indirect roles of G4s in CTCF recruitment.

1 September 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Mikhail KrasavinMikhail Krasavin
Mikhail Krasavin
ALAlexei Lukin
Alexei Lukin
Tatiana VedekhinaTatiana Vedekhina
Tatiana Vedekhina
OMOlga Manicheva
Olga Manicheva
MDMarine Dogonadze
Marine Dogonadze
PYPiotr Yablonsky
Piotr Yablonsky

1 March 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Mikhail KrasavinMikhail Krasavin
Mikhail Krasavin
ALAlexei Lukin
Alexei Lukin
Tatiana VedekhinaTatiana Vedekhina
Tatiana Vedekhina
OMOlga Manicheva
Olga Manicheva
MDMarine Dogonadze
Marine Dogonadze
ESEvgeny Sokolovich
Evgeny Sokolovich

25 May 2022 in Viruses
Verified
Journal Article
Open access
PDF file
DMDaria Matyushkina
Daria Matyushkina
VSVarvara Shokina
Varvara Shokina
PTPolina Tikhonova
Polina Tikhonova
Valentin ManuveraValentin Manuvera
Valentin Manuvera
DSDmitriy Shirokov
Dmitriy Shirokov
VGVadim Govorun
Vadim Govorun
COVID-19 caused by SARS-CoV-2 is continuing to spread around the world and drastically affect our daily life. New strains appear, and the severity of the course of the disease itself seems to be decreasing, but even people who have been ill on an outpatient basis suffer post-COVID consequences. Partly, it is associated with the autoimmune reactions, so debates about the development of new vaccines and the need for vaccination/revaccination continue. In this study we performed an analysis of the antibody response of patients with COVID-19 to linear and conformational epitopes of viral proteins using ELISA, chip array and western blot with analysis of correlations between antibody titer, disease severity, and complications. We have shown that the presence of IgG antibodies to the nucleoprotein can deteriorate the course of the disease, induce multiple direct COVID-19 symptoms, and contribute to long-term post-covid symptoms. We analyzed the cross reactivity of antibodies to SARS-CoV-2 with own human proteins and showed that antibodies to the nucleocapsid protein can bind to human proteins. In accordance with the possibility of HLA presentation, the main possible targets of the autoantibodies were identified. People with HLA alleles A01:01; A26:01; B39:01; B15:01 are most susceptible to the development of autoimmune processes after COVID-19.

1 December 2021 in Biochimie
Verified
Journal Article
Closed access
Vladimir Borisovich TsvetkovVladimir Borisovich Tsvetkov
Vladimir Borisovich Tsvetkov
AVAnna Varizhuk
Anna Varizhuk
LKLiubov Kozlovskaya
Liubov Kozlovskaya
ASAnna Shtro
Anna Shtro
OLOlga Lebedeva
Olga Lebedeva
MLMaria Lagarkova
Maria Lagarkova

6 June 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
ALAlexey Lukin
Alexey Lukin
Tatiana VedekhinaTatiana Vedekhina
Tatiana Vedekhina
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
NZNikolay Zhurilo
Nikolay Zhurilo
Mikhail KrasavinMikhail Krasavin
Mikhail Krasavin
Hydrohydrazination of propargylamides with BocNHNH2under Zn(OTf)2catalysis gave dihydro-1,2,4-triazines which can be efficiently aromatizedin situwith K3[Fe(CN)6]. This provides a new entry into the medicinally important 1,2,4-triazine core.